ORC6, Negatively Regulated by miR-1-3p, Promotes Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells.
ORC6
cells
hepatocellular carcinoma
miR-1-3p
microRNA
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
01
2021
accepted:
30
06
2021
entrez:
16
8
2021
pubmed:
17
8
2021
medline:
17
8
2021
Statut:
epublish
Résumé
In recent years, microRNA-1-3p (miR-1-3p) has been linked to the progression of multiple cancers, whereas little is known about its role in hepatocellular carcinoma (HCC). Herein, we investigated the function of miR-1-3p in HCC, and its regulatory function on origin recognition complex subunit 6 (ORC6). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed for detecting the expression levels of miR-1-3p and ORC6 mRNA in HCC samples and cell lines. ORC6 expression at the protein level was quantified by Western blot. After gain-of-function and loss-of-function models were established, cell counting kit-8 (CCK-8) assays, Transwell assays, flow cytometry, and 5-Ethynyl-2'-deoxyuridine (EdU) assay were performed for examining cell proliferation, migration, invasion, cell cycle, and apoptosis. The targeting relationship between miR-1-3p and ORC6 was confirmed with bioinformatic analysis and dual-luciferase reporter assays. The expression of miR-1-3p was reduced in HCC samples and cell lines. Overexpression of miR-1-3p suppressed the proliferation, migration, and invasion, and induced cell-cycle arrest and apoptosis of HCC cells, whereas the opposite effects were induced by miR-1-3p inhibition. ORC6 is identified as a novel target of miR-1-3p, the expression of which is negatively correlated with miR-1-3p expression in HCC tissues. ORC6 overexpression facilitated the proliferation, migration, invasion, and cell cycle progression, and reduced apoptosis of HCC cells, whereas the opposite effects were induced by ORC6 knockdown. What is more, ORC6 overexpression counteracted the biological functions of miR-1-3p in HCC cells. MiR-1-3p targets ORC6 to suppress the proliferation, migration, invasion, and cell cycle progression, and promote apoptosis of HCC cells.
Sections du résumé
BACKGROUND
BACKGROUND
In recent years, microRNA-1-3p (miR-1-3p) has been linked to the progression of multiple cancers, whereas little is known about its role in hepatocellular carcinoma (HCC). Herein, we investigated the function of miR-1-3p in HCC, and its regulatory function on origin recognition complex subunit 6 (ORC6).
METHODS
METHODS
Quantitative real-time polymerase chain reaction (qRT-PCR) was performed for detecting the expression levels of miR-1-3p and ORC6 mRNA in HCC samples and cell lines. ORC6 expression at the protein level was quantified by Western blot. After gain-of-function and loss-of-function models were established, cell counting kit-8 (CCK-8) assays, Transwell assays, flow cytometry, and 5-Ethynyl-2'-deoxyuridine (EdU) assay were performed for examining cell proliferation, migration, invasion, cell cycle, and apoptosis. The targeting relationship between miR-1-3p and ORC6 was confirmed with bioinformatic analysis and dual-luciferase reporter assays.
RESULTS
RESULTS
The expression of miR-1-3p was reduced in HCC samples and cell lines. Overexpression of miR-1-3p suppressed the proliferation, migration, and invasion, and induced cell-cycle arrest and apoptosis of HCC cells, whereas the opposite effects were induced by miR-1-3p inhibition. ORC6 is identified as a novel target of miR-1-3p, the expression of which is negatively correlated with miR-1-3p expression in HCC tissues. ORC6 overexpression facilitated the proliferation, migration, invasion, and cell cycle progression, and reduced apoptosis of HCC cells, whereas the opposite effects were induced by ORC6 knockdown. What is more, ORC6 overexpression counteracted the biological functions of miR-1-3p in HCC cells.
CONCLUSION
CONCLUSIONS
MiR-1-3p targets ORC6 to suppress the proliferation, migration, invasion, and cell cycle progression, and promote apoptosis of HCC cells.
Identifiants
pubmed: 34395415
doi: 10.3389/fcell.2021.652292
pmc: PMC8358308
doi:
Types de publication
Journal Article
Langues
eng
Pagination
652292Informations de copyright
Copyright © 2021 Chen, Bao, Hu, Wu and Tong.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Cell Mol Med. 2018 Jul;22(7):3526-3536
pubmed: 29664235
PLoS One. 2008;3(12):e4054
pubmed: 19112505
Nature. 2018 Jul;559(7713):217-222
pubmed: 29973722
Cancer Treat Rev. 2019 Jan;72:28-36
pubmed: 30447470
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8870-8877
pubmed: 31696489
Science. 2002 Aug 9;297(5583):1026-31
pubmed: 12169736
Mol Cell Biochem. 2017 Mar;427(1-2):187-199
pubmed: 28000044
Onco Targets Ther. 2019 Mar 22;12:2149-2157
pubmed: 30962696
Target Oncol. 2019 Apr;14(2):115-123
pubmed: 30805831
Neoplasma. 2018;65(1):89-96
pubmed: 29322793
Front Genet. 2020 Feb 27;11:176
pubmed: 32180804
Int J Mol Sci. 2019 Feb 02;20(3):
pubmed: 30717412
Gastroenterology. 2019 Jan;156(2):510-524
pubmed: 30287171
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9150-5
pubmed: 12878722
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10672-7
pubmed: 19541634
Mol Cancer. 2017 Aug 30;16(1):149
pubmed: 28854942
N Engl J Med. 2019 Apr 11;380(15):1450-1462
pubmed: 30970190
J Transl Med. 2018 Jun 9;16(1):161
pubmed: 29885652
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7373-8
pubmed: 21502537
Int J Cardiol. 2019 Sep 15;291:158-167
pubmed: 31151766